Genetron Health’s semiconductor-based NGS system gets Chinese approval
Genetron Health has been granted approval by China’s National Medical Products Administration (NMPA) for GENETRON S5, its semiconductor-based next-generation sequencing system (NGS system). With the ... Read More
Astellas Pharma acquires US biotech company Xyphos Biosciences
Astellas acquisition of Xyphos : Japanese pharma company Astellas Pharma has acquired US biotech company Xyphos Biosciences in a deal worth up to $665 million ... Read More
Allergan bags Ubrelvy FDA approval for migraine treatment
Ubrelvy FDA approval : Irish pharma company Allergan has bagged approval from the US Food and Drug Administration (FDA) for Ubrelvy (ubrogepant) tablets for the ... Read More
Micro Labs, Mylan secure FDA approval for first generics of Eliquis
Micro Labs and Mylan Pharmaceuticals have secured approval from the US Food and Drug Administration (FDA) for two applications for the first generics of Eliquis ... Read More
FDA rejects Correvio Pharma’s anti-arrhythmic drug Brinavess
Correvio Pharma said that the US Food and Drug Administration (FDA) decided not to approve its anti-arrhythmic drug Brinavess (vernakalant IV). In this connection, the ... Read More
Roche signs $2.85bn deal with Sarepta for SRP-9001 DND gene therapy
Roche has signed a licensing deal worth up to $2.85 billion with Sarepta Therapeutics for the exclusive ex-US commercial rights to the latter’s SRP-9001 (AAVrh74.MHCK7.micro-dystrophin), ... Read More
NeuroVive completes enrollment in KL1333 clinical trial for mitochondrial disease
KL1333 clinical trial : Swedish biotech company NeuroVive Pharmaceutical has wrapped up recruitment of healthy volunteers in the second part of its ongoing phase Ia/b ... Read More
LABORIE to acquire Clinical Innovations from EQT for $525m
LABORIE acquisition of Clinical Innovations : LABORIE Medical Technologies has agreed to acquire Utah-based Clinical Innovations for $525 million from EQT Mid Market US fund ... Read More
J&J takeover of Verb Surgical : J&J strikes deal with Verily for full ownership in robotic surgery company
J&J takeover of Verb Surgical : Johnson & Johnson (J&J) has agreed to take full ownership in US robotic surgery company Verb Surgical by acquiring ... Read More
J&J takeover of Verb Surgical : J&J strikes deal with Verily for full ownership in robotic surgery company
J&J takeover of Verb Surgical : Johnson & Johnson (J&J) has agreed to take full ownership in US robotic surgery company Verb Surgical by acquiring ... Read More